Physician
LA Pain Doctor INC
LA Pain Doctor INC was paid $1.27M by Medicaid between Jan 2018 and Dec 2024, across 29 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 50% of everything it billed.
33Billing provider infoLA PAIN DOCTOR INC
LA PLACE, LA 70068
LA PLACE, LA 70068
33aNPI1760856215assigned 11/20/2015
33bProvider typePain Medicine Physician
28Total paid$1.27M
24GClaims60,734
24DCodes billed29
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,936 | $15K | |
| 2019 | 4,379 | $8K | |
| 2020 | 6,636 | $12K | |
| 2021 | 3,561 | $31K | |
| 2022 | 8,648 | $217K | |
| 2023 | 19,046 | $507K | |
| 2024incomplete | 12,528 | $485K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 50% | 26,417 | 20,780 | $641K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 23% | 11,897 | 9,891 | $289K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 7.7% | 2,011 | 1,612 | $98K |
| 64635 | 5.1% | 642 | 421 | $66K | |
| 64493 | 4.7% | 723 | 555 | $60K | |
| 64494 | 2.4% | 719 | 552 | $30K | |
| 64636 | 2.1% | 609 | 404 | $27K | |
| 27096 | 1.2% | 254 | 204 | $15K | |
| 77002 | <1% | 555 | 392 | $10K | |
| 20610 | <1% | 481 | 365 | $10K | |
| 62323 | <1% | 91 | 63 | $7K | |
| 64490 | <1% | 96 | 62 | $7K |
17 more codes
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 870 | $7K |
| 64491 | <1% | 92 | $4K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,741 | $2K |
| 99497 | <1% | 121 | $841.47 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 612 | $197.39 |
| 99199 | Unlisted special service, procedure or report | <1% | 29 | $35.08 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 2,566 | $5.94 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 584 | $2.86 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 1,172 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 83 | $0.00 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 0% | 750 | $0.00 |
| G8950 | Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented | 0% | 22 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 90 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 2,146 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 4,088 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 248 | $0.00 |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHIJAZI, FIRAS (OWNER)